Literature DB >> 16390824

Nitrotyrosine formation and apoptosis in rat models of ocular injury.

Mutay Aslan1, Iclal Yücel, Yusuf Akar, Gültekin Yücel, M Akif Ciftçioğlu, Salih Sanlioglu.   

Abstract

This study was performed to examine inducible nitric oxide synthase (NOS-2) expression, nitrotyrosine formation and apoptosis in rats with elevated intraocular pressure (IOP) and/or ocular inflammation. Ocular inflammation was induced via injection of intra-vitreal lipopolysaccharide (LPS) while IOP was elevated by episcleral vessel cauterization. Animals were randomized to one of the following conditions: elevated IOP, LPS, elevated IOP+LPS, and control. Immunohistochemical staining and western blot analysis of retinal lysates revealed NOS-2 and nitrotyrosine immunoreactivity in all disease groups. NOS-2 expression and protein nitration was significantly greater in rats with elevated IOP+LPS compared to elevated IOP, LPS, and control groups. Nitrite levels in the retina affirmed significantly increased levels of nitric oxide generation in LPS-treated rats with elevated IOP (346+/-23.8 microM) vs LPS-treated, elevated IOP and control groups (195.6+/-12.6, 130+/-2.5 and 76.6+/-15.6 microM, respectively). Retinal TUNEL staining showed apoptosis in all diseased groups. Percent of apoptotic cells was significantly greater in the elevated IOP+LPS group compared to LPS-treated or elevated IOP groups. Presented data illustrates that both elevated IOP and ocular inflammation augment NOS-2 expression, retinal protein nitration and apoptosis in rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16390824     DOI: 10.1080/10715760500456219

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  10 in total

1.  Manganese porphyrin reduces retinal injury induced by ocular hypertension in rats.

Authors:  Serdar Dogan; Mustafa Unal; Nihal Ozturk; Piraye Yargicoglu; Aysegul Cort; Ivan Spasojevic; Ines Batinic-Haberle; Mutay Aslan
Journal:  Exp Eye Res       Date:  2011-06-12       Impact factor: 3.467

Review 2.  Pharmacological neuroprotection for glaucoma.

Authors:  Glyn Chidlow; John P M Wood; Robert J Casson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Mechanism of glyceraldehyde-3-phosphate dehydrogenase inactivation by tyrosine nitration.

Authors:  Vikram Palamalai; Masaru Miyagi
Journal:  Protein Sci       Date:  2010-02       Impact factor: 6.725

Review 4.  Oxidative stress and potential applications of free radical scavengers in glaucoma.

Authors:  Mutay Aslan; Serdar Dogan; Ertan Kucuksayan
Journal:  Redox Rep       Date:  2013-03-06       Impact factor: 4.412

5.  Lycium barbarum polysaccharides reduce neuronal damage, blood-retinal barrier disruption and oxidative stress in retinal ischemia/reperfusion injury.

Authors:  Suk-Yee Li; Di Yang; Chung-Man Yeung; Wing-Yan Yu; Raymond Chuen-Chung Chang; Kwok-Fai So; David Wong; Amy C Y Lo
Journal:  PLoS One       Date:  2011-01-26       Impact factor: 3.240

Review 6.  Neuroprotection in glaucoma.

Authors:  Sushil K Vasudevan; Viney Gupta; Jonathan G Crowston
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

7.  Inducible and endothelial nitric synthetase expression and nitrotyrosine accumulation in iris vasculature of patients with primary open-angle glaucoma: a pilot study.

Authors:  Wojciech Rokicki; Małgorzata Żaba; Dorota Wyględowska-Promieńska; Adam Kabiesz; Edyta Reichman-Warmusz; Marlena Brzozowa; Wojciech Majewski; Romuald Wojnicz
Journal:  Med Sci Monit       Date:  2015-01-07

8.  Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model.

Authors:  Nagehan Can; Onur Catak; Burak Turgut; Tamer Demir; Nevin Ilhan; Tuncay Kuloglu; Ibrahim Hanifi Ozercan
Journal:  Drug Des Devel Ther       Date:  2015-06-02       Impact factor: 4.162

Review 9.  Carotenoids in the Management of Glaucoma: A Systematic Review of the Evidence.

Authors:  Drake W Lem; Dennis L Gierhart; Pinakin Gunvant Davey
Journal:  Nutrients       Date:  2021-06-06       Impact factor: 5.717

10.  α-Lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction.

Authors:  Denise M Inman; Wendi S Lambert; David J Calkins; Philip J Horner
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.